Our Stories is our page dedicated to highlighting who we are as a company – much like a blog, but better. These stories encompass the many ways we positively impact health, from interesting features about our work in areas like biopharma, oncology and distribution to articles that spotlight the impactful work our company and our employees are doing to fulfill our mission. Read the stories here: https://lnkd.in/g6S33Ruq
Love this!
Sr. Talent Sourcing Partner ♦ McKesson (a Fortune 9 company) ♦ Corporate Talent Finder in Healthcare ♦ Certified Diversity Recruiter
Advancing health outcomes for ALL
Our Stories is our page dedicated to highlighting who we are as a company – much like a blog, but better. These stories encompass the many ways we positively impact health, from interesting features about our work in areas like biopharma, oncology and distribution to articles that spotlight the impactful work our company and our employees are doing to fulfill our mission. Read the stories here: https://lnkd.in/g6S33Ruq
Introducing "Our Stories," a dedicated page that showcases who we are as a company—think of it like a blog, but even better. Here, you'll find compelling narratives about how we make a positive impact on health. From insightful features on our work in biopharma, oncology, and distribution to articles spotlighting the meaningful contributions of our company and employees in fulfilling our mission, "Our Stories" encapsulates it all. Dive into these inspiring stories here: https://lnkd.in/gcE99MYe
Our Stories is our page dedicated to highlighting who we are as a company – much like a blog, but better. These stories encompass the many ways we positively impact health, from interesting features about our work in areas like biopharma, oncology and distribution to articles that spotlight the impactful work our company and our employees are doing to fulfill our mission. Read the stories here: https://lnkd.in/g6S33Ruq
In a survey of practices in The US Oncology Network, 52% said they rarely or never interact with life sciences company representatives. In the video below, Ontada Learn VP & GM Claude Bergeron shares how tools like our eLearn Now can support and complement both practices and life sciences companies by sharing relevant information when providers need it most. #LifeSciences #ProviderEducation
#Cancer_Supportive_Care_Products Market Foresees a Substantial Revenue Surge from 2023 to 2032 https://lnkd.in/dBu3v4kW The increase in the rise of #cancer #cases and rising #awareness of supportive care products will drive the #growth of this #market. The increase in the spending capacity and improved #health #care has made it possible for a wider population to use these products which in-turn is adding to the market revenue. Amgen Merck Group Johnson & Johnson Heron Therapeutics, Inc. Novartis TESARO, Inc. F. Hoffmann-La Roche Ltd Helsinn Group #Cancer_Supportive_Care_Products #healthcare #business_opportunities #marketanalysis #marketresearch #opportunities #business #future
Join our very own Clinical Supply Manager, Danielle L. Hagen, as she shares valuable insights at this week's 3rd BioPharma Supply Chain & Logistics Nexus. Don’t miss out on learning about the intricacies and innovations in personalized cancer vaccine supply chains. See you there! #BioPharmaNexusConference #BioPharma #SupplyChain
#Cancer_Supportive_Care_Products Market - Upcoming Business Future Growth and Forecast To 2032. >> https://lnkd.in/dBu3v4kW The increase in the rise of #cancer #cases and rising #awareness of supportive care products will drive the #growth of this #market. The increase in the spending capacity and improved #health #care has made it possible for a wider population to use these products which in-turn is adding to the market revenue. Amgen Merck Group Johnson & Johnson Heron Therapeutics, Inc. Novartis TESARO, Inc. F. Hoffmann-La Roche Ltd Helsinn Group #Cancer_Supportive_Care_Products #healthcare #business_opportunities #marketanalysis #marketresearch #opportunities #business #future
In this #blog, John McDermott, VP of Scientific Consulting, discusses the benefits of evaluating targeted oncology molecules in healthy volunteers and how our #TranslationalPharmaceutics® platform can help accelerate drug product optimization. Read here: https://bit.ly/3HZLW54
Learn how a leading precision oncology company saved $450,000 per year on overnight shipping costs with Neev systems' custom integration solution for efficient kit tracking. Read more below! Follow Neev Systems and contact us for more insights today! #GuardantHealth #FoundationForFuture #KitTracking #EnterpriseIntegration
In the next blog in our oncology series, Stacy Hurt 🌻, Kristina Reeder, and Nichola Gokool examine how patients’ input is crucial in drug development and how Parexel incorporates patient voice throughout the research process. Our experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Read and download the full blog https://lnkd.in/g59djn7n. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech
Are you struggling with the financials of your oncology service line? Take control with the financial performance assessment from Oncology Convergence. Our experts dive deep into your data, providing actionable insights and tailor-made solutions. Don't let revenue opportunities slip away - contact us for a thorough audit and assessment today. Oncology Convergence: Where Treatment and Profitability Meet #OncologyRevenueCycle #RevenueOptimization https://lnkd.in/gQ-usfvJ
Superior Service Matters
2moGrateful for McKesson as a Breast Cancer Survivor and current employee. Thank You!!